学术论文:  | 
   发表文章(近三年,10篇以内) 1) Xu H(#),   Li D(#),   Ma J, Zhao Y, Xu L, Tian R, Liu Y, Sun L*, Su J*. The IL-33/ST2 axis affects   tumor growth by regulating mitophagy in macrophages and reprogramming their   polarization. Cancer Biol Med. 2021; 18(1): 172-183. doi: 10.20892/j.issn.2095-3941.2020.0211. 2) Hou Y, Liu Y, Liang S, Ding R, Mo S, Yan D*, Li D*. The novel target: exosoms derived from M2   macrophage. Int Rev Immunol. 2021;40(3):183-196.   doi: 10.1080/08830185.2020.1800687. 3) Liu L#, Zhang P#, Wang Y, Cui W*, Li D*.   The relationship between the use of artificial sweeteners and cancer: A   meta-analysis of case–control studies. Food Sci Nutr. 2021; 9(8):4589-4597. doi:10.1002/fsn3.2395. 4) Zhao Z#, Liu T#,   Liang Y, Cui W, Li D, Zhang G, Deng Z, Chen M, Sha K, Xiao W, Xie H,   Li J*. N2-Polarized Neutrophils Reduce Inflammation in Rosacea by Regulating   Vascular Factors and Proliferation of CD4+ T Cells. J Invest Dermatol.   2022;142(7):1835-1844.e2. doi: 10.1016/j.jid.2021.12.009. 5) Wei C, Liu L, Liu R, Dai W, Cui W*, Li D*. Association   between the Phytochemical Index and Overweight/Obesity: A Meta-Analysis. Nutrients.   2022; 14(7): 1429. doi: 10.3390/nu14071429.  6) Zhang W, He D, Wei Y,   Shang S, Li D*, Wang L*. Suppression of Aspergillus fumigatus   Germination by Neutrophils Is Enhanced by Endothelial-Derived CSF3   Production. Front Microbiol. 2022; 13:837776. doi:   10.3389/fmicb.2022.837776.  7) Liu R, Liu L, Wei C, Li D*. IL-33/ST2   immunobiology in coronary artery disease: A systematic review and   meta-analysis. Front Cardiovasc Med. 2022;9:990007. doi:   10.3389/fcvm.2022.990007. 8) Liu L, Liu S, Liu R,   Dai W, Wei C, Cui W, Li D*. K5BW12O40   Induces the Apoptosis of A549 Cells by Regulating Caspase-3. J Chem. 2022;   2022: 6484040. doi: 10.1155/2022/6484040.  9) Liu L, Liu R, Wei C, Li D*, Gao X*. The   role of IL-17 in lung cancer growth. Cytokine. 2023; 169:156265.   doi: 10.1016/j.cyto.2023.156265.  10) Gao X, Ma H, Niu J*, Li D*.   FcγRIIB expression increases during primary biliary   cholangitis. Mol Immunol. 2023; 162:30-37. doi: 10.1016/j.molimm.2023.08.001.     |